Cycurion, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
19. Earnings Per Share
- EARNINGS PER SHARE
| Table 21.1: Details of Basic and Dilutive (Loss)/Earnings Per Share | ||
|---|---|---|
| For the Year Ended December 31, | ||
| 2025 | 2024 | |
| Basic net (loss)/income per share: | ||
| Numerator | ||
| Net (loss)/income including non-controlling interests | $(24,059,084) | $1,229,601 |
| Less: Net loss attributable to non-controlling interest | (393,376) | - |
| Net (loss)/income attributable to common stockholders - basic | (23,665,708) | 1,229,601 |
| Denominator | ||
| Weighted average shares outstanding - basic | 1,760,310 | 282,437 |
| Basic net (loss)/income per share attributable to common stockholders | $(13.44) | $4.35 |
| Diluted net (loss)/income per share: | ||
| Numerator | ||
| Net (loss)/income attributable to common stockholders - basic | $(23,665,708) | $1,229,601 |
| Add back interest for subordinated convertible promissory note | 43,333 | 276,667 |
| Net (loss)/income attributable to common stockholders - diluted | $(23,622,375) | $1,506,268 |
| Denominator | ||
| Weighted average shares outstanding - basic | 1,760,310 | 282,437 |
| Weighted-average effect of potentially dilutive securities: | ||
| Conversion of subordinated convertible promissory note | 3,333 | 58,347 |
| Conversion of Series A Convertible Preferred Stock | - | 70,203 |
| Conversion of Series B Convertible Preferred Stock | - | 175,182 |
| Conversion of Series C Convertible Preferred Stock | - | 1,212 |
| Exercise of investor and placement agent warrants | - | 317,548 |
| Weighted average shares outstanding - diluted | 1,763,643 | 904,929 |
| Dilutive net (loss)/income per share attributable to common stockholders | $(13.39) | $1.66 |
| Table 21.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect | ||
|---|---|---|
| For the Year Ended December 31, | ||
| 2025 | 2024 | |
| Conversion of Series A Convertible Preferred Stock | 92,332 | - |
| Conversion of Series B Convertible Preferred Stock | 28,090 | - |
| Conversion of Series C Convertible Preferred Stock | 1,202 | - |
| Conversion of Series D Convertible Preferred Stock | 10,092 | - |
| Conversion of Series E Convertible Preferred Stock | 2 | - |
| Exercise of investor and placement agent warrants | 922,845 | 317,548 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.